Hmdb loader
Record Information
Version5.0
StatusDetected and Quantified
Creation Date2006-05-22 15:12:08 UTC
Update Date2022-09-22 17:43:49 UTC
HMDB IDHMDB0002752
Secondary Accession Numbers
  • HMDB0062524
  • HMDB02752
  • HMDB62524
Metabolite Identification
Common NameProstaglandin A2
DescriptionProduced by the seminal vesicles, prostaglandins are a group of lipid compounds that are derived enzymatically from fatty acids. Technically hormones, the prostanoid class of fatty acid derivatives is a subclass of eicosanoids. The eicosanoids consist of the prostaglandins (PGs), thromboxanes (TXs), leukotrienes (LTs), and lipoxins (LXs). The PGs and TXs are collectively identified as prostanoids. Prostaglandins were originally shown to be synthesized in the prostate gland, thromboxanes from platelets (thrombocytes), and leukotrienes from leukocytes, hence the derivation of their names. All mammalian cells except erythrocytes synthesize eicosanoids. These molecules are extremely potent, able to cause profound physiological effects at very dilute concentrations. All eicosanoids function locally at the site of synthesis through receptor-mediated G-protein linked signaling pathways. Prostaglandin A is a cyclopentenone and is an endogenous metabolite derived from arachidonic acid. It exhibits potent cellular anti-proliferative activity in vivo and in vitro. Excess PGA2 causes an accumulation in both S and G2/M, and a marked decrease in G1. There is also an increase in DNA content preceeding the G0/G1 peak (indicative of apoptotic body formation) mediated by changes in expression levels of Bax and Bcl-2.
Structure
Data?1582752255
Synonyms
ValueSource
(15S)-PGA2ChEBI
(15S)-Prostaglandin a2ChEBI
5,6-cis-PGA2ChEBI
MedullinChEBI
PGA2ChEBI
7-[2-(3-Hydroxy-1-octenyl)-5-oxo-3-cyclopenten-1-yl]-5-heptenoic acidHMDB
(5Z,13E,15S)-15-Hydroxy-9-oxoprosta-5,10,13-trien-1-Oic acidHMDB
(+)-Prostaglandin a2HMDB
15(S)-Hydroxy-9-oxo-5-cis-10,13-trans-prostatrienoateHMDB
15(S)-Hydroxy-9-oxo-5-cis-10,13-trans-prostatrienoic acidHMDB
15(S)-Hydroxy-9-oxo-5-cis-10,13-trans-prostenoateHMDB
15(S)-Hydroxy-9-oxo-5-cis-10,13-trans-prostenoic acidHMDB
15(S)-Prostaglandin a2HMDB
15Α-hydroxy-9-oxo-cis-5,10,trans-13-prostatrienecarboxylateHMDB
15Α-hydroxy-9-oxo-cis-5,10,trans-13-prostatrienecarboxylic acidHMDB
15Α-hydroxy-9-oxo-cis-5,10,trans-13-prostatrienoateHMDB
15Α-hydroxy-9-oxo-cis-5,10,trans-13-prostatrienoic acidHMDB
NSC 165561HMDB
(5Z,13E,15S)-15-Hydroxy-9-oxoprosta-5, 10,13-triene-1-Oic acidHMDB
(Z)-7-((1R,2S)-2-((e)-(3S)-3-Hydroxyoct-1-enyl)-5-oxocyclopent-3-enyl)hept-5-enoic acidHMDB
Prostaglandin A2HMDB
Chemical FormulaC20H30O4
Average Molecular Weight334.4498
Monoisotopic Molecular Weight334.214409448
IUPAC Name(5Z)-7-[(1R,2S)-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-5-oxocyclopent-3-en-1-yl]hept-5-enoic acid
Traditional Nameprostaglandin A2
CAS Registry Number13345-50-1
SMILES
CCCCC[C@H](O)\C=C\[C@H]1C=CC(=O)[C@@H]1C\C=C/CCCC(O)=O
InChI Identifier
InChI=1S/C20H30O4/c1-2-3-6-9-17(21)14-12-16-13-15-19(22)18(16)10-7-4-5-8-11-20(23)24/h4,7,12-18,21H,2-3,5-6,8-11H2,1H3,(H,23,24)/b7-4-,14-12+/t16-,17-,18+/m0/s1
InChI KeyMYHXHCUNDDAEOZ-FOSBLDSVSA-N
Chemical Taxonomy
Description Belongs to the class of organic compounds known as prostaglandins and related compounds. These are unsaturated carboxylic acids consisting of a 20 carbon skeleton that also contains a five member ring, and are based upon the fatty acid arachidonic acid.
KingdomOrganic compounds
Super ClassLipids and lipid-like molecules
ClassFatty Acyls
Sub ClassEicosanoids
Direct ParentProstaglandins and related compounds
Alternative Parents
Substituents
  • Prostaglandin skeleton
  • Long-chain fatty acid
  • Hydroxy fatty acid
  • Fatty acid
  • Unsaturated fatty acid
  • Ketone
  • Cyclic ketone
  • Secondary alcohol
  • Carboxylic acid derivative
  • Carboxylic acid
  • Monocarboxylic acid or derivatives
  • Organic oxide
  • Organic oxygen compound
  • Alcohol
  • Hydrocarbon derivative
  • Carbonyl group
  • Organooxygen compound
  • Aliphatic homomonocyclic compound
Molecular FrameworkAliphatic homomonocyclic compounds
External Descriptors
Ontology
Physiological effectNot Available
Disposition
Process
RoleNot Available
Physical Properties
StateSolid
Experimental Molecular Properties
PropertyValueReference
Melting PointNot AvailableNot Available
Boiling PointNot AvailableNot Available
Water SolubilityNot AvailableNot Available
LogPNot AvailableNot Available
Experimental Chromatographic PropertiesNot Available
Predicted Molecular Properties
PropertyValueSource
Water Solubility0.021 g/LALOGPS
logP4.08ALOGPS
logP4.38ChemAxon
logS-4.2ALOGPS
pKa (Strongest Acidic)4.4ChemAxon
pKa (Strongest Basic)-1.6ChemAxon
Physiological Charge-1ChemAxon
Hydrogen Acceptor Count4ChemAxon
Hydrogen Donor Count2ChemAxon
Polar Surface Area74.6 ŲChemAxon
Rotatable Bond Count12ChemAxon
Refractivity99.09 m³·mol⁻¹ChemAxon
Polarizability38.66 ųChemAxon
Number of Rings1ChemAxon
BioavailabilityYesChemAxon
Rule of FiveYesChemAxon
Ghose FilterYesChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleNoChemAxon
Predicted Chromatographic Properties

Predicted Collision Cross Sections

PredictorAdduct TypeCCS Value (Å2)Reference
DeepCCS[M+H]+192.47430932474
DeepCCS[M-H]-189.87130932474
DeepCCS[M-2H]-224.40630932474
DeepCCS[M+Na]+199.63530932474
AllCCS[M+H]+188.032859911
AllCCS[M+H-H2O]+185.232859911
AllCCS[M+NH4]+190.632859911
AllCCS[M+Na]+191.432859911
AllCCS[M-H]-187.932859911
AllCCS[M+Na-2H]-189.232859911
AllCCS[M+HCOO]-190.832859911

Predicted Retention Times

Underivatized

Chromatographic MethodRetention TimeReference
Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter)). Predicted by Afia on May 17, 2022.6.82 minutes32390414
Predicted by Siyang on May 30, 202215.5765 minutes33406817
Predicted by Siyang using ReTip algorithm on June 8, 20220.86 minutes32390414
AjsUoB = Accucore 150 Amide HILIC with 10mM Ammonium Formate, 0.1% Formic Acid36.2 seconds40023050
Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid2772.8 seconds40023050
Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid272.2 seconds40023050
Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid185.9 seconds40023050
Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid185.5 seconds40023050
RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid314.0 seconds40023050
Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid675.8 seconds40023050
BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid478.3 seconds40023050
HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate)121.5 seconds40023050
UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid1543.7 seconds40023050
BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid525.1 seconds40023050
UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid1470.6 seconds40023050
SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid464.6 seconds40023050
RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid420.9 seconds40023050
MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate318.0 seconds40023050
KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA295.6 seconds40023050
Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water8.1 seconds40023050

Predicted Kovats Retention Indices

Underivatized

MetaboliteSMILESKovats RI ValueColumn TypeReference
Prostaglandin A2CCCCC[C@H](O)\C=C\[C@H]1C=CC(=O)[C@@H]1C\C=C/CCCC(O)=O4422.2Standard polar33892256
Prostaglandin A2CCCCC[C@H](O)\C=C\[C@H]1C=CC(=O)[C@@H]1C\C=C/CCCC(O)=O2544.3Standard non polar33892256
Prostaglandin A2CCCCC[C@H](O)\C=C\[C@H]1C=CC(=O)[C@@H]1C\C=C/CCCC(O)=O2765.4Semi standard non polar33892256

Derivatized

Derivative Name / StructureSMILESKovats RI ValueColumn TypeReference
Prostaglandin A2,1TMS,isomer #1CCCCC[C@@H](/C=C/[C@H]1C=CC(=O)[C@@H]1C/C=C\CCCC(=O)O)O[Si](C)(C)C2804.7Semi standard non polar33892256
Prostaglandin A2,1TMS,isomer #2CCCCC[C@H](O)/C=C/[C@H]1C=CC(=O)[C@@H]1C/C=C\CCCC(=O)O[Si](C)(C)C2715.9Semi standard non polar33892256
Prostaglandin A2,1TMS,isomer #3CCCCC[C@H](O)/C=C/[C@H]1C=CC(O[Si](C)(C)C)=C1C/C=C\CCCC(=O)O2832.9Semi standard non polar33892256
Prostaglandin A2,2TMS,isomer #1CCCCC[C@@H](/C=C/[C@H]1C=CC(=O)[C@@H]1C/C=C\CCCC(=O)O[Si](C)(C)C)O[Si](C)(C)C2783.5Semi standard non polar33892256
Prostaglandin A2,2TMS,isomer #2CCCCC[C@@H](/C=C/[C@H]1C=CC(O[Si](C)(C)C)=C1C/C=C\CCCC(=O)O)O[Si](C)(C)C2906.9Semi standard non polar33892256
Prostaglandin A2,2TMS,isomer #3CCCCC[C@H](O)/C=C/[C@H]1C=CC(O[Si](C)(C)C)=C1C/C=C\CCCC(=O)O[Si](C)(C)C2824.2Semi standard non polar33892256
Prostaglandin A2,3TMS,isomer #1CCCCC[C@@H](/C=C/[C@H]1C=CC(O[Si](C)(C)C)=C1C/C=C\CCCC(=O)O[Si](C)(C)C)O[Si](C)(C)C2897.0Semi standard non polar33892256
Prostaglandin A2,3TMS,isomer #1CCCCC[C@@H](/C=C/[C@H]1C=CC(O[Si](C)(C)C)=C1C/C=C\CCCC(=O)O[Si](C)(C)C)O[Si](C)(C)C2722.7Standard non polar33892256
Prostaglandin A2,3TMS,isomer #1CCCCC[C@@H](/C=C/[C@H]1C=CC(O[Si](C)(C)C)=C1C/C=C\CCCC(=O)O[Si](C)(C)C)O[Si](C)(C)C2989.0Standard polar33892256
Prostaglandin A2,1TBDMS,isomer #1CCCCC[C@@H](/C=C/[C@H]1C=CC(=O)[C@@H]1C/C=C\CCCC(=O)O)O[Si](C)(C)C(C)(C)C3046.3Semi standard non polar33892256
Prostaglandin A2,1TBDMS,isomer #2CCCCC[C@H](O)/C=C/[C@H]1C=CC(=O)[C@@H]1C/C=C\CCCC(=O)O[Si](C)(C)C(C)(C)C2957.7Semi standard non polar33892256
Prostaglandin A2,1TBDMS,isomer #3CCCCC[C@H](O)/C=C/[C@H]1C=CC(O[Si](C)(C)C(C)(C)C)=C1C/C=C\CCCC(=O)O3083.2Semi standard non polar33892256
Prostaglandin A2,2TBDMS,isomer #1CCCCC[C@@H](/C=C/[C@H]1C=CC(=O)[C@@H]1C/C=C\CCCC(=O)O[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C3263.6Semi standard non polar33892256
Prostaglandin A2,2TBDMS,isomer #2CCCCC[C@@H](/C=C/[C@H]1C=CC(O[Si](C)(C)C(C)(C)C)=C1C/C=C\CCCC(=O)O)O[Si](C)(C)C(C)(C)C3368.1Semi standard non polar33892256
Prostaglandin A2,2TBDMS,isomer #3CCCCC[C@H](O)/C=C/[C@H]1C=CC(O[Si](C)(C)C(C)(C)C)=C1C/C=C\CCCC(=O)O[Si](C)(C)C(C)(C)C3307.7Semi standard non polar33892256
Prostaglandin A2,3TBDMS,isomer #1CCCCC[C@@H](/C=C/[C@H]1C=CC(O[Si](C)(C)C(C)(C)C)=C1C/C=C\CCCC(=O)O[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C3597.9Semi standard non polar33892256
Prostaglandin A2,3TBDMS,isomer #1CCCCC[C@@H](/C=C/[C@H]1C=CC(O[Si](C)(C)C(C)(C)C)=C1C/C=C\CCCC(=O)O[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C3229.7Standard non polar33892256
Prostaglandin A2,3TBDMS,isomer #1CCCCC[C@@H](/C=C/[C@H]1C=CC(O[Si](C)(C)C(C)(C)C)=C1C/C=C\CCCC(=O)O[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C3170.6Standard polar33892256
Spectra

GC-MS Spectra

Spectrum TypeDescriptionSplash KeyDeposition DateSourceView
Experimental GC-MSGC-MS Spectrum - Prostaglandin A2 GC-MS (1 MEOX; 2 TMS)splash10-0059-4920000000-710b83c9a85f25a1d16c2014-06-16HMDB team, MONA, MassBankView Spectrum
Experimental GC-MSGC-MS Spectrum - Prostaglandin A2 GC-MS (1 MEOX; 2 TMS)splash10-0059-4910000000-db2352d8228dc4eb9a182014-06-16HMDB team, MONA, MassBankView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - Prostaglandin A2 GC-MS (Non-derivatized) - 70eV, Positivesplash10-02bo-6293000000-822f7d0eecbf0f64639b2017-09-20Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - Prostaglandin A2 GC-MS (2 TMS) - 70eV, Positivesplash10-0209-9313300000-440ddaf4dbe3670c7d282017-10-06Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - Prostaglandin A2 GC-MS (Non-derivatized) - 70eV, PositiveNot Available2021-10-12Wishart LabView Spectrum

MS/MS Spectra

Spectrum TypeDescriptionSplash KeyDeposition DateSourceView
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Prostaglandin A2 10V, Positive-QTOFsplash10-014j-0169000000-4a6959ca7f335a56a9552017-10-06Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Prostaglandin A2 20V, Positive-QTOFsplash10-06ds-3192000000-3ab10f6f0529d4cee7b92017-10-06Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Prostaglandin A2 40V, Positive-QTOFsplash10-0l0j-9120000000-0ee0572914cf0adba33b2017-10-06Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Prostaglandin A2 10V, Negative-QTOFsplash10-001i-0019000000-17f7af2365a9dd00dcd62017-10-06Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Prostaglandin A2 20V, Negative-QTOFsplash10-0159-2159000000-c7485c819c912f1819ce2017-10-06Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Prostaglandin A2 40V, Negative-QTOFsplash10-0a4i-9430000000-9a1157c44c36556975192017-10-06Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Prostaglandin A2 10V, Positive-QTOFsplash10-00kb-0095000000-52912cbc0a9bfa8936842021-09-22Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Prostaglandin A2 20V, Positive-QTOFsplash10-015a-6592000000-19736467f3757c7e23992021-09-22Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Prostaglandin A2 40V, Positive-QTOFsplash10-069u-9410000000-58ab2d3e8090e7cf4fdb2021-09-22Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Prostaglandin A2 10V, Negative-QTOFsplash10-014i-0049000000-81a3f3dd4586250ad9d52021-09-23Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Prostaglandin A2 20V, Negative-QTOFsplash10-00m0-0894000000-add76968bc35e889a4d52021-09-23Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Prostaglandin A2 40V, Negative-QTOFsplash10-05mo-9850000000-b9e815d2e66be565edc32021-09-23Wishart LabView Spectrum
Biological Properties
Cellular Locations
  • Extracellular
  • Membrane (predicted from logP)
Biospecimen Locations
  • Blood
  • Urine
Tissue LocationsNot Available
Pathways
Normal Concentrations
BiospecimenStatusValueAgeSexConditionReferenceDetails
BloodDetected and Quantified0.0000448 +/- 0.000496 uMAdult (>18 years old)Both
Normal
details
BloodDetected and Quantified0.0010 +/- 0.0002 uMAdult (>18 years old)Male
Normal
details
BloodDetected and Quantified0.0000747 +/- 0.000254 uMAdult (>18 years old)Both
Normal
details
BloodDetected and Quantified0.0008 +/- 0.0002 uMAdult (>18 years old)Male
Normal
details
BloodDetected and Quantified0.000167 +/- 0.000401 uMAdult (>18 years old)Not Specified
Normal
details
BloodDetected and Quantified0.0019 +/- 0.0004 uMAdult (>18 years old)Male
Normal
details
BloodDetected and Quantified0.0027 +/- 0.0008 uMAdult (>18 years old)Male
Normal
details
Abnormal Concentrations
BiospecimenStatusValueAgeSexConditionReferenceDetails
UrineDetected but not QuantifiedNot QuantifiedNot SpecifiedNot SpecifiedCancer patients undergoing total body irradiation details
Associated Disorders and Diseases
Disease ReferencesNone
Associated OMIM IDsNone
DrugBank IDNot Available
Phenol Explorer Compound IDNot Available
FooDB IDFDB023060
KNApSAcK IDNot Available
Chemspider ID4444403
KEGG Compound IDC05953
BioCyc IDNot Available
BiGG IDNot Available
Wikipedia LinkNot Available
METLIN IDNot Available
PubChem Compound5280880
PDB IDNot Available
ChEBI ID27820
Food Biomarker OntologyNot Available
VMH IDHC02203
MarkerDB IDNot Available
Good Scents IDNot Available
References
Synthesis ReferenceGrieco, Paul A.; Abood, Norman. Facile retro Diels-Alder reaction of a pentamethyltricyclo[5.2.1.02,6]decenone derivative: synthesis of (+)-15(S)-prostaglandin A2. Journal of the Chemical Society, Chemical Communications (1990), (5), 410-12.
Material Safety Data Sheet (MSDS)Download (PDF)
General References
  1. Simons K, Toomre D: Lipid rafts and signal transduction. Nat Rev Mol Cell Biol. 2000 Oct;1(1):31-9. [PubMed:11413487 ]
  2. Watson AD: Thematic review series: systems biology approaches to metabolic and cardiovascular disorders. Lipidomics: a global approach to lipid analysis in biological systems. J Lipid Res. 2006 Oct;47(10):2101-11. Epub 2006 Aug 10. [PubMed:16902246 ]
  3. Sethi JK, Vidal-Puig AJ: Thematic review series: adipocyte biology. Adipose tissue function and plasticity orchestrate nutritional adaptation. J Lipid Res. 2007 Jun;48(6):1253-62. Epub 2007 Mar 20. [PubMed:17374880 ]
  4. Lingwood D, Simons K: Lipid rafts as a membrane-organizing principle. Science. 2010 Jan 1;327(5961):46-50. doi: 10.1126/science.1174621. [PubMed:20044567 ]
  5. Gunstone, Frank D., John L. Harwood, and Albert J. Dijkstra (2007). The lipid handbook with CD-ROM. CRC Press.